All Resources

This page provides filters and search facilities across all types of CF resources contained within the ECFS website.

Additionally, you can visit the specific resource type pages as follows:

More information on CF publications can be found here: Publications

June 2018

Title: A Specialized Method of Sputum Collection and Processing for Therapeutic Interventions in Cystic Fibrosis
References
J Cyst Fibros. 2018 Jun 27. pii: S1569-1993(18)30625-8. doi: 10.1016/j.jcf.2018.06.001. 

June 2018

Title: RNA sequencing data from neutrophils of patients with cystic fibrosis reveals potential for developing biomarkers for pulmonary exacerbations
References

June 2018

Title: Electrochemical measurement of membrane cholesterol correlates with CFTR function and is HDAC6-dependent
References
J Cyst Fibros. 2018 Jun 22. pii: S1569-1993(18)30630-1. doi: 10.1016/j.jcf.2018.06.005

June 2018

Title: Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function.
References
J Cyst Fibros. 2018 Jun 21. pii: S1569-1993(18)30623-4. doi: 10.1016/j.jcf.2018.05.018.
Title: AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations
References
J Cyst Fibros. 2018 Jun 21. pii: S1569-1993(18)30618-0. doi: 10.1016/j.jcf.2018.05.013.

June 2018

Title: Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.
References
J Cyst Fibros. 2018 Jun 16. pii: S1569-1993(18)30620-9. doi: 10.1016/j.jcf.2018.05.015. 

June 2018

Title: Combination potentiator ('co-potentiator') therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators.
References
J Cyst Fibros. 2018 Jun 11. pii: S1569-1993(18)30592-7. doi: 10.1016/j.jcf.2018.05.010.

June 2018

Title: Physiological and pharmacological characterization of the N1303K mutant CFTR.
References
J Cyst Fibros. 2018 Jun 7. pii: S1569-1993(18)30593-9. doi: 10.1016/j.jcf.2018.05.011. 

June 2018

Title: Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes.
References
J Cyst Fibros. 2018 Jun 6. pii: S1569-1993(18)30587-3. doi: 10.1016/j.jcf.2018.05.005. 

June 2018

Title: Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis
References
J Cyst Fibros. 2018 Jun 5. pii: S1569-1993(18)30588-5. doi: 10.1016/j.jcf.2018.05.006

June 2018

Title: Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding
References
J Cyst Fibros. 2018 Jun 1. pii: S1569-1993(18)30591-5. doi: 10.1016/j.jcf.2018.05.009.